WOCKPHARMA Financial Statements

WOCKPHARMA Annual Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 19.30 (4.80) (28) (1.90)
Op profit growth (573) (153) 6,404 (86)
EBIT growth (140) 167 141 25.50
Net profit growth (136) (1,091) (89) 211
Profitability ratios (%)        
OPM 9.23 (2.30) 4.19 0.05
EBIT margin 2.20 (6.50) (2.30) (0.70)
Net profit margin (7.60) 25.30 (2.40) (15)
RoCE 1.06 (2.60) (0.90) (0.40)
RoNW (1.70) 5.67 (0.60) (4.90)
RoA (0.90) 2.50 (0.20) (2)
Per share ratios ()        
EPS (19) 62.60 (3.90) --
Dividend per share -- -- -- --
Cash EPS (34) 39.70 (26) (69)
Book value per share 267 305 241 258
Valuation ratios        
P/E (14) 6.10 (41) --
P/CEPS (7.70) 9.61 (6) (9.80)
P/B 0.99 1.25 0.66 2.60
EV/EBIDTA 17.60 101 33.10 87.70
Payout (%)        
Dividend payout -- -- -- --
Tax payout (58) (64) (60) 9.08
Liquidity ratios        
Debtor days 104 146 142 92.60
Inventory days 88.60 100 99.20 91
Creditor days (108) (108) (104) (56)
Leverage ratios        
Interest coverage (0.20) 0.71 0.24 0.11
Net debt / equity 0.47 0.71 1.24 0.93
Net debt / op. profit 6.01 (38) 27.80 1,457
Cost breakup ()        
Material costs (39) (42) (42) (46)
Employee costs (23) (28) (26) (24)
Other costs (28) (32) (27) (30)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 3,230 2,708 2,844 3,937
yoy growth (%) 19.30 (4.80) (28) (1.90)
Raw materials (1,267) (1,137) (1,203) (1,798)
As % of sales 39.20 42 42.30 45.70
Employee costs (749) (763) (743) (937)
As % of sales 23.20 28.20 26.10 23.80
Other costs (916) (871) (778) (1,200)
As % of sales 28.40 32.20 27.40 30.50
Operating profit 298 (63) 119 1.83
OPM 9.23 (2.30) 4.19 0.05
Depreciation (247) (246) (224) (150)
Interest expense (299) (249) (276) (255)
Other income 20 132 38.80 120
Profit before tax (228) (426) (342) (283)
Taxes 132 271 204 (26)
Tax rate (58) (64) (60) 9.08
Minorities and other 35 983 68.70 58.60
Adj. profit (61) 828 (69) (250)
Exceptional items (183) (142) -- (358)
Net profit (244) 686 (69) (608)
yoy growth (%) (136) (1,091) (89) 211
NPM (7.60) 25.30 (2.40) (15)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Profit before tax (228) (426) (342) (283)
Depreciation (247) (246) (224) (150)
Tax paid 132 271 204 (26)
Working capital 380 30.40 (1,181) 207
Other operating items -- -- -- --
Operating cashflow 36.60 (371) (1,543) (251)
Capital expenditure 1,969 1,443 1,360 1,129
Free cash flow 2,006 1,073 (183) 878
Equity raised 3,436 2,529 4,738 6,335
Investments (90) (91) (2.20) (363)
Debt financing/disposal (1,173) 39.20 2,354 3,041
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 4,179 3,550 6,907 9,891
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 72 55 55.40 55.30
Preference capital -- -- -- 234
Reserves 3,777 3,321 2,616 2,619
Net worth 3,849 3,376 2,672 2,909
Minority interest
Debt 2,198 2,674 3,582 3,141
Deferred tax liabilities (net) 316 302 324 139
Total liabilities 6,716 6,735 6,963 6,518
Fixed assets 4,804 4,722 5,087 4,503
Intangible assets
Investments -- -- 0.45 0.45
Deferred tax asset (net) 861 672 722 381
Net working capital 645 1,049 886 1,185
Inventories 769 799 690 819
Inventory Days 86.90 108 88.50 --
Sundry debtors 918 918 1,243 1,274
Debtor days 104 124 159 --
Other current assets 773 645 461 525
Sundry creditors (1,017) (720) (915) (867)
Creditor days 115 97 117 --
Other current liabilities (798) (593) (593) (567)
Cash 406 292 268 449
Total assets 6,716 6,735 6,963 6,518
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018
Gross Sales 3,230 2,708 2,844 3,566 3,937
Excise Duty -- -- -- -- --
Net Sales 3,230 2,708 2,844 3,566 3,937
Other Operating Income -- -- -- -- --
Other Income 20 1,476 184 116 120
Total Income 3,250 4,184 3,028 3,682 4,057
Total Expenditure ** 3,115 2,773 2,725 3,604 4,293
PBIDT 135 1,411 303 77.70 (236)
Interest 299 249 276 265 255
PBDT (164) 1,162 27.50 (187) (492)
Depreciation 247 246 224 164 150
Minority Interest Before NP -- -- -- -- --
Tax 38 192 6.07 (42) 50.80
Deferred Tax (170) 36 (159) (93) (25)
Reported Profit After Tax (279) 688 (43) (217) (667)
Minority Interest After NP (35) 2 25.80 (22) --
Net Profit after Minority Interest (244) 686 (69) (195) (667)
Extra-ordinary Items (166) -- -- -- (330)
Adjusted Profit After Extra-ordinary item (78) 686 (69) (195) (337)
EPS (Unit Curr.) (20) 62 (6.30) (44) (55)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 72 55.40 55.40 55.30 55.30
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 4.18 52.10 10.70 2.18 (6)
PBDTM(%) (5.10) 42.90 0.97 (5.30) (12)
PATM(%) (8.60) 25.40 (1.50) (6.10) (17)
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity